In studies conducted on Swedish AD/MCI patients (N = 119; Age: 60–80 years) [40] and (N = 141) [41], elevated plasma and serum CCL2 levels were found compared to those in the HC. This evidence concerns the gene CCL2 and Alzheimer disease.